Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Erwin

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Diagnostic Microbiology and Infectious Disease|January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridoneR N Jones, M E Erwin, D J Biedenbach, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella speciesD M Johnson, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporinB M Briggs, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628M S Barrett, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitisJ L Croco, M E Erwin, J M Jennings, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1990
Antimicrobial spectrum of cefpirome combined with tazobactam against the Bacteroides fragilis groupR N Jones, J L Croco, M S Barrett, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporinM E Erwin, R N Jones, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephemsR N Jones, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compoundsR N Jones, M S Barrett, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin esterR N Jones, M E Erwin, M S Barrett, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Diagnostic Microbiology and Infectious Disease|January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridoneR N Jones, M E Erwin, D J Biedenbach, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella speciesD M Johnson, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporinB M Briggs, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628M S Barrett, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|December 1, 1994
Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitisJ L Croco, M E Erwin, J M Jennings, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1990
Antimicrobial spectrum of cefpirome combined with tazobactam against the Bacteroides fragilis groupR N Jones, J L Croco, M S Barrett, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro evaluation of GR69153, a novel catechol-substituted cephalosporinM E Erwin, R N Jones, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephemsR N Jones, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compoundsR N Jones, M S Barrett, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin esterR N Jones, M E Erwin, M S Barrett, et al.
Pageof 9